318. Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) in Hispanic/Latinx and Black Participants: Efficacy, Bone and Renal Safety Results from a Pooled Analysis of 7 Clinical Trials

BACKGROUND: People of color are underrepresented in clinical trials. TAF has shown improved renal and bone safety vs. TDF. We pooled 7 studies to evaluate efficacy/safety of TAF vs. TDF for ART initiation/switch in Hispanic/Latinx and Black participants. METHODS: Data from Hispanic/Latinx and Black...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: DeJesus, Edwin, Federico Andrade Villanueva, Jaime, Ramon Arribas Lopez, Jose, Brinson, Cynthia, Crofoot, Gordon, Daar, Eric S, Koenig, Ellen, Podzamczer, Daniel, Ramgopal, Moti, Santana, Jorge, Santiago, Lizette, Tebas, Pablo, Zorrilla, Carmen, Guo, Susan, Liu, Ya-Pei, Zhong, Lijie, Brainard, Diana M, Carter, Christoph C, Temme, Lauren, Das, Moupali
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6809442/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.391
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados